Opinion statement
No Class I studies of the effectiveness of thymectomy for myasthenia gravis (MG) have been performed. Most Class II studies comparing outcomes in MG patients with and without thymectomy demonstrated higher MG remission and improvement rates in patients undergoing thymectomy. However, these Class II studies were also consistently confounded by important differences between MG patients in surgical and nonsurgical groups. Myasthenia gravis patients undergoing thymectomy were younger, more often women and were more likely to have severe myasthenia. The authors of this paper cannot determine from these Class II studies whether the observed association between thymectomy and improved MG outcomes was a result of a thymectomy benefit or was merely a result of the multiple differences in baseline characteristics between the surgical and nonsurgical groups. The authors concluded that the benefit of thymectomy in non-thymomatous autoimmune MG has not been conclusively established. Thus, for patients with non-thymomatous autoimmune myasthenia gravis, thymectomy should only be considered an option to increase the probability of remission or improvement. The quality standards subcommittee of the American Academy of Neurology recently adopted this position [1].
Similar content being viewed by others
References and Recommended Reading
Gronseth GS, Barohn RJ: Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Neurology 2000, 55:7–15.
Schluep M, Wilcox N, Vincent A, et al.: Acetylcholine receptors in human thymic myoid cells in situ: an immunological study. Ann Neurol 1987, 22:212–222.
Blalock A, Mason MF, Morgan HJ, et al.: Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed. Ann Surg 1939, 110:544–561.
Blalock A, Harvey AM, Ford FR, Lilientha JL Jr.: The treatment of myasthenia gravis by removal of the thymus gland: preliminary report. JAMA 1945, 127:1089–1096.
Blalock A: Thymectomy in the treatment of myasthenia gravis: report of twenty cases. J Thoracic Surg 1944, 13:316–339.
Christensen PB, Jensen TS, Tsiropoulos I, et al.: Mortality and survival in myasthenia gravis: a Danish population based study. J Neurol Neurosurg Psych 1998, 64:78–83.
Evoli A, Batocchi AP, Lino M, Tonali P: Thymectomy for early-onset myasthenia gravis: a case-control study [abstract]. Neuromuscul Disord 1998, 8:270.
Beekman R, Kuks JBM, Oosterhuis HJGH: Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 1997, 244:112–118.
Werneck LC, Cunha FMF, Scola RH: Myasthenia gravis: a study comparing thymectomy and conservative treatment [abstract]. Neurology 1996, 46:A334.
Evoli A, Batocchi AP, Tonali P, et al.: Thymectomy for late-onset myasthenia gravis [abstract]. Neurology 1996, 46:A310.
Beghi E, Antozzi C, Batocchi AP, et al.: Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 1991, 106:213–220. Although from 1991, this is the only study of outcomes in a large cohort MG patients receiving and not receiving thymectomy that controls for multiple confounding differences in MG patient baseline characteristics of prognostic importance.
Valli G, Jann S, Premoselli S, Scarlato G: Myasthenia gravis treatment: twelve years experience on 110 patients. Ital J Neurol Sci 1987, 8:593–601.
Mantegazza R, Beghi E, Pareyson D, et al.: A multicenter follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990, 237:339–344.
Scoppetta C, Tonali P, Evoli A, et al.: Treatment of myasthenia gravis: report of 139 patients. J Neurol 1979, 222:11–21.
Donaldson DH, Ansher M, Horan S, et al.: The relationship of age to outcome in myasthenia gravis. Neurology 1990, 40:786–790.
Papatestas AE, Genkins G, Kornfeld P, et al.: Effects of thymectomy in myasthenia gravis. Ann Surg 1987, 206:79–88.
Grob D, Arsura EL, Brunner NG, Namba T: The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 1987, 505:472–499.
Grob D, Brunner NG, Namba T: The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci 1981, 377:652–669.
Grob D: Course and management of myasthenia gravis. JAMA 1953, 153:529–532.
Scadding GK, Havard CWH, Lange MJ, Domb I: The long-term experience of thymectomy for myasthenia gravis. J Neurol Neurosurg Psych 1985, 48:401–406.
Rodriguez M, Gomez MR, Howard FM, Taylor WF: Myasthenia gravis in children: long-term follow-up. Ann Neurol 1983, 13:504–510.
Oosterhuis HJ: Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci 1981, 377:678–690.
Buckingham JM, Howard FM, Bernatz PE, et al.: The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg 1976, 184:453–458.
Emeryk B, Strugalska MH: Evaluation of results of thymectomy in myasthenia gravis. J Neurol 1976, 211:155–168.
Perlo VP, Poskanzer D, Castleman B, et al.: The role of thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci 1971, 183:308–315.
Perlo VP, Poskanzer DC, Schwab RS, et al.: Myasthenia gravis: evaluation of treatment in 1355 patients. Neurology 1966, 16:431–439.
Schwab RS, Leland CC, Boston AB: Sex and age in myasthenia gravis as critical factors in incidence and remission. JAMA 1953, 153:1270–1273.
Zeldowicz LR, Saxton GD: Myasthenia gravis: comparative evaluation of medical and surgical treatment. Can Med Assoc J 1969, 101:88–93.
Henson RA, Stern GM, Thompson VC: Thymectomy for myasthenia gravis. Brain 1965, 88:11–28.
Simpson JA: An evaluation of thymectomy in myasthenia gravis. Brain 1958, 81:112–144.
Eaton LM, Clagett OT: Present status of thymectomy in treatment of myasthenia gravis. Am J Med 1955, 19:703–717.
Eaton LM, Clagett OT: Thymectomy in the treatment of myasthenia gravis. JAMA 1950, 19:963–967.
Eaton LM, Clagett OT, Bastron JA: Myasthenia gravis without tumor: comparison of results in surgical and nonsurgical patients. Res Publ Assoc Res Nerv Ment Dis 1953, 32:107.
Jaretzki III A, Barohn RJ, Emstoff RM, et al.: Myasthenia gravis: recommendations for clinical research standards. Neurology 2000, 55:16–23. This paper proposes carefully defined and standardized outcome measures for myasthenia gravis treatment trials. It is of particular interest to investigators.
Jaretzki III A: Thymectomy for myasthenia gravis: analysis of the controversies regarding technique and results. Neurology 1997, 48(suppl):S52-S63. Although the conclusions are based on Class III data alone, this paper includes an excellent discussion of different thymectomy surgical techniques including their potential advantages and disadvantages.
Medawar PB: Induction and Intuition in Scientific Thought. Philadelphia: American Philosophical Society; 1969.
Papatestas AE, Gabriel G, Kornfeld P: Comparison of the results of the transcervical and transsternal thymectomy in myasthenia gravis. Ann NY Acad Sci 1981, 377:766–778.
Masaoka A, Monden M: Comparison of the results of transsternal simple, transcervical simple, and extended thymectomy. Ann NY Acad Sci 1981, 377:755–765.
Seggia JC, Abreu P, Takatani M: Plasmapheresis as preparatory method for thymectomy in myasthenia gravis. Arq Neuropsiquiatr 1995, 53:411–415.
Chevalley C, Spiliopoulos A, de Perrot M, et al.: Perioperative medical management and outcome following thymectomy for myasthenia gravis. Can J Anesth 2001, 48:446–451.
Bulkley GB, Bass KN, Stephenson GR, et al.: Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 1997, 226:324–334.
Mack MJ, Scruggs G: Video-assisted thoracic surgery thymectomy for myasthenia gravis. Chest Surg Clin N Am 1998, 8:809–825.
Monden Y, Nakahara K, Kagotani K, et al.: Effects of preoperative duration of symptoms on patients with myasthenia gravis. Ann Thorac Surg 1984, 38:287–291.
Sackett DL, Haynes RB, Guyatt GH, Tugwell P: Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown and Company, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gronseth, G.S., Barohn, R.J. Thymectomy for myasthenia gravis. Curr Treat Options Neurol 4, 203–209 (2002). https://doi.org/10.1007/s11940-002-0037-x
Issue Date:
DOI: https://doi.org/10.1007/s11940-002-0037-x